Taimed Biologics Inc.

TaiMed Biologics, a Taipei‑based biotech, advances HIV therapeutics with its Trogarzo IV/TMB‑355 monoclonal antibody platform and phase‑1/2 candidates TMB‑365/TMB‑380, supported by Genentech/Biogen alliances and Samsung Biologics manufacturing.

Headquarters: Taiwan (TWN)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Medical and Diagnostic Laboratories

HQ: Taipei City

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
4147	Taimed Biologics Inc. Cap: 16.1B	EQUITY	TWO	TWD	TW0004147004	Active	📈